Aptevo Therapeutics (APVO)
(Delayed Data from NSDQ)
$2.17 USD
-0.28 (-11.43%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $2.17 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Aptevo Therapeutics Inc. has a market cap of $1.85M, which represents its share price of $2.45 multiplied by its outstanding shares number of 0.76M. As a small-cap company, APVO's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
APVO 2.17 -0.28(-11.43%)
Will APVO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APVO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APVO
Are Medical Stocks Lagging Aptevo Therapeutics (APVO) This Year?
Aptevo Therapeutics (APVO) Upgraded to Buy: Here's What You Should Know
APVO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for APVO
Aptevo Therapeutics files to sell 8.25M shares of common stock for holders
Aptevo Therapeutics (APVO) Schedules Offering of 8.25 Million Shares
Aptevo Therapeutics files to sell 8.25M shares of common stock for holders
Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous
12 Health Care Stocks Moving In Friday's Intraday Session